Home

Mark N. Lampert, Director: Kymera Therapeutics KYMR Sell · Filed 06/26

Trade details

Type
Insider sale
Amount
$66,839,080.5
Shares · price
627,597 sh · $106.50 a share
Held after
1,592,261 sh
Trade date
26/06/26
Filed
26/06/26
Days to filing
0 days

Sold 28.3% of holdings

Share of holding sold
28.3%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

Mark N. Lampert's recent trades

  • Mark N. Lampert

    SellKymera Therapeutics

    $89.2M

    Filed 06/26

  • Mark N. Lampert

    SellKymera Therapeutics

    $12.1M

    Filed 06/26

  • Mark N. Lampert

    SellKymera Therapeutics

    $5.5M

    Filed 06/26

  • Mark N. Lampert

    SellMoonLake Immunotherapeutics

    $32.4M

    Filed 04/02

  • Mark N. Lampert

    SellMoonLake Immunotherapeutics

    $26.3M

    Filed 04/02

Mark N. Lampert, Director — sold $66.8M of Kymera Therapeutics KYMR · 28.3% of holdings | Whalegun